Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,
Tag: VLA15
Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,